Keywords: Questor Pharma, BioVectra, M&A, Contract manufacturing, APIs

Questcor Pharmaceuticals to acquire BioVectra for around $50 million

Article | 04 January 2013

California, USA-based Questcor Pharmaceuticals (Nasdaq: QCOR) has signed a definitive agreement to acquire all issued and outstanding shares of BioVectra ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

BioVectra

Questor Pharmaceuticals

Go to company listing